NeoTX Therapeutics
Rehovot
About NeoTX Therapeutics
NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $65.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2020)
- Website: predictivetx.com
- Phone: 609 718 2305
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/neotx-therapeutics-86298 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.